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Summary
Semaphorins play an essential role in axonal guidance,
and emerging evidence points to diverse functions of
several Semaphorin family members in the immune
system. Semaphorin 7A (Sema7A) promotes axonal
growth in the central nervous system. Here, we show
that Sema7A also plays a critical role in negative regu-
lation of T cell activation and function. T cells deficient
in Sema7A exhibit enhanced homeostatic and antigen-
inducedproliferative response.Moreover, autoreactive
Sema7A-deficient T cells mediate aggressive auto-
immune disease. The deficiency in Sema7A leads to
defective TCR downmodulation and T cell hyperres-
ponsiveness. These results demonstrate an important
role of Sema7A in limiting autoimmune responses
and add to growing evidence of shared signaling path-
ways used by the immune and nervous systems.
Introduction
Semaphorins are neuronal guidance factors that were
initially characterized by their ability to inhibit axonal mi-
gration via chemorepulsive mechanisms, which induce
cytoskeletal rearrangement and growth cone collapse
(Kolodkin et al., 1992, 1993; Luo et al., 1993). Semaphor-
ins transduce the repulsive signal through receptors of
the plexin family (Tamagnone et al., 1999), and in addi-
tion, two of the class IV semaphorins interact with recep-
tors structurally unrelated to plexins (Kumanogoh et al.,
2000, 2002b).
Several members of the semaphorin family have been
characterized with respect to their function in immunity.
Sema4D is a 150 kDa transmembrane protein, which be-
longs to the class IV semaphorin subfamily (Delaire
et al., 1998). In lymphoid organs, Sema4D is abundant
on resting T cells. The receptor for Sema4D in lymphoid
tissues is CD72 (Elhabazi et al., 2003; Kumanogoh et al.,
2000). CD72 functions as a negative regulator of B cell
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Cornell University, Ithaca, New York 14853.responses, and Sema4D binds CD72 and turns off its in-
hibitory signaling during T cell-mediated B cell activa-
tion (Kumanogoh and Kikutani, 2001). Another immune
semaphorin, Sema4A is expressed by DCs, B cells,
and by activated T cells. Sema4A costimulates T cell ac-
tivation by interaction with receptor Tim-2 (Kumanogoh
et al., 2002a). Studies of Sema4A-deficient mice show
that DC-derived Sema4A is important for T cell priming,
while T cell-derived Sema4A is involved in developing
Th1 responses (Kumanogoh et al., 2005).
Semaphorin 7A, the only GPI-linked protein in sema-
phorin family, is prominently expressed in the embryo
and in the lymphoid organs and the nervous system of
adult mice (Sato and Takahashi, 1998). Sema7A is a cellu-
lar homolog of viral semaphorins encoded by vaccinia
and herpesvirus (Comeau et al., 1998; Lange et al.,
1998; Xu et al., 1998) and was demonstrated to bind to
the cellular receptor Plexin C1 in vitro (Tamagnone
et al., 1999). Sema7A can induce monocyte chemotaxis
and cytokine production and is expressed in activated
lymphocytes and thymocytes (Holmes et al., 2002; Mine
et al., 2000), suggesting an immune function for this mol-
ecule. In addition, Sema7A is highly expressed on most
human T lymphocytes and natural killer cells (Angelisova
et al., 1999). Sema7A knockout animals exhibited dimin-
ished axonal tracts formation, while treatment with solu-
ble Sema7A enhanced axonal outgrowth (Pasterkamp
et al., 2003). Sema7A binding to neurons induced activa-
tion of focal adhesion kinase (FAK) and extracellular reg-
ulated kinases (ERKs) (Pasterkamp et al., 2003). These ef-
fects of Sema7A were mediated by b1-integrin and were
independent of Plexin C1 (Pasterkamp et al., 2003). Thus,
Sema7A binds to at least two receptorswith very different
activities, and the significance of these interactions in
various tissue types remains to be clarified.
The expression of Sema7A on T lymphocytes and the
acquisition of its homolog by two viral families suggest
that this molecule may have an important specific func-
tion in lymphocytes. Here, we investigate the role of
Sema7A in T cells and demonstrate that it plays a T
cell-intrinsic inhibitory role and is essential for limiting
T cell-mediated autoimmunity.
Results
Sema7A-Deficient T Cells Are Hyperresponsive
Sema7A is expressed in naive CD4 and CD8 T cells, and
its expression is increased in activated CD4 T cells and
remains elevated in differentiated T helper 1 (Th1) lym-
phocytes (Figure S1A). Sema7A mRNA is detected in
dendritic cells (DCs) and macrophages but is not promi-
nently expressed in B cells (Figures S1A and S1B). To
address the function of Sema7A in the immune system,
we first compared T cell responses in Sema7A2/2 ani-
mals and their wt littermates. Mice were immunized
with a model protein antigen, chicken ovalbumin (OVA)
emulsified in adjuvant. Six days after immunization,
CD4 T cells were purified from the draining lymph nodes
and restimulated with wt antigen-presenting cells (APC)
pulsed with different doses of OVA. Sema7A-deficient
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antigen, compared to the wt T cells (Figure 1A), suggest-
ing that Sema7A may have a negative regulatory role in
T cell activation. Sema7A deficiency leading to increased
proliferation could reside either in antigen-presenting
cells or in T cells. To distinguish between these possibil-
ities, we performed in vitro T cell activation assays with
naive OTII TCR transgenic CD4 T cells stimulated with
cognate peptide presented by wt APCs. OTII CD4 T cells
on Sema7A2/2 background showed dramatically in-
creased proliferative response to cognate antigen pre-
sented by wt APC, compared to OTII Sema7A+/+ T cells
(Figure 1B). This result demonstrated that the increased
T cell responsiveness was due to the lack of Sema7A in
T cells and suggested that this molecule may have an
inhibitory function that regulates proliferation of T cells.
In order to further study the inhibitory role of Sema7A
in T cell activation, we prepared recombinant soluble
Sema7A-Fc. Addition of 100 mg/ml of soluble Sema7A-
Fc to wt OTII transgenic T cells stimulated with OVA-
pulsed DCsresulted in a significant decrease in T cellpro-
liferation, compared to addition of Fc alone (Figure 1C).
This result provides further indication for an inhibitory
function of Sema7A in T cell activation.
We next addressed the role of Sema7A expression in
DCs by comparing the maturation and T cell activation
by wt and Sema7A2/2 DCs. No significant differences
were observed in DC maturation induced by various
TLR ligands in vitro (Figure S2A). Wt and Sema7A2/2
DCs had equivalent ability to activate naive T lympho-
cytes in vitro (Figure S2B) and in vivo (Figure S2C). These
findings indicate that the increased proliferative re-
sponse seen in Sema7A2/2 T cells is likely to be T cell
autonomous and independent of Sema7A deficiency
in APCs.
Severe EAE in Sema7A-Deficient Mice
To examine the in vivo function of Sema7A in CD4
T cells, we employed the animal model of multiple scle-
rosis, experimental autoimmune encephalomyelitis
(EAE), which is an inflammatory disease of the central
nervous system (CNS) mediated primarily by Th1 cells
(Kuchroo et al., 2002; Wong et al., 1999). Upon induction
of EAE, self-reactive activated T cells transmigrate into
the CNS, where they activate resident microglia and at-
tract further influx of monocytes and other cells through
the secretion of proinflammatory cytokines (Raine, 1997;
Ruddle et al., 1990). To analyze the role of Sema7A in
T cell responses in vivo, we immunized Sema7A2/2
and wt littermate mice with myelin oligodendrocyte
glycoprotein (MOG35–55) peptide in complete Freud’s
adjuvant (CFA). This immunization regimen leads to the
induction of EAE within 12–15 days (see Experimental
Procedures). Comparison of mean disease scores (aver-
aged from three independent experiments) showed
a dramatically increased disease index in Sema7A2/2
mice (Figures 2A and 2E), which was due to the high
mortality (w60%) (Figure 2E) of these animals near the
time of disease onset. Analysis of disease progression
in surviving Sema7A2/2 mice showed a single, lingering
paralysis episode in the Sema7A-deficient animals, in
contrast to a later onset, earlier disease remittance,
and typical consecutive episodes of relapse in the wt
littermates (Figures 2B and 2E). Serum levels of IFNgmeasured on day 10 postimmunization were elevated
(Figure 2C), and, consistently, a larger number of infil-
trating lymphocytes was found in the spinal cord sec-
tions from moribund Sema7A2/2 animals compared
to wt animals on the same day postimmunization
(Figure 2D). Additionally, the level of IL-12 in the serum
of Sema7A2/2 mice was also found to be elevated
(Figure S3A). As the aggravated autoimmunity could re-
sult from a deficiency in cytokines that play a regulatory
role in inflammation, we measured the levels of IL-10
and TGF-b in the serum of animals prior to and post
EAE immunization but found no significant differences
in their levels between the Sema7A+/+ and Sema7A2/2
littermates (Figures S3B and S3C). Therefore, the high
mortality of Sema7A2/2 animals at the onset of EAE is
likely a result of increased T cell activation, accelerated
infiltration of T cells into the CNS, and the elevated levels
of IFNg produced by activated T cells. This phenotype is
indicative of an exacerbated autoimmune response in
Sema7A2/2 animals.
The CD25 CD4 regulatory T cells play an important role
in autoimmune disease protection (Paust and Cantor,
2005; Sakaguchi and Sakaguchi, 2005), and their defi-
ciency could contribute to the severity of EAE observed in
Sema7A2/2 animals. We therefore addressed the in vivo
functionality of regulatory T cells deficient in Sema7A by
using a T cell transfer model of colitis. In this model, intra-
peritoneal injection of a small number of purified CD4
RBhigh CD25negative T cells into a lymphopenic host results
in colitis and is associated with a rapid weight loss in the
Figure 1. Function of Sema7A in T Cell Proliferation
(A and B) Enhanced CD4 T cell responses in Sema7A-deficient mice
compared with wild-type mice. (A) CD4 T cell responses from OVA
immunized mice. (B) Proliferation of naive OTII CD4 Sema7A2/2 or
Sema7A+/+ T cells activated with wild-type APCs.
(C) Addition of soluble, recombinant Sema7A-FC (100 mg/ml) inhibits
proliferation of naive OTII CD4 T cells stimulated with Ovalbumin-
pulsed DCs. As a control, recombinant IgG-FC fragment was added
at 100 mg/ml. T cell-proliferative responses are expressed as the
average 6 SE of three animals per group in (A) or as the mean 6
SE of triplicate cultures in (B) and (C).
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593Figure 2. Increased Morbidity and Alteration
in the Clinical Course of EAE in Sema7A2/2
Mice
EAE was induced and scored in Sema7A+/+
(n = 14) and Sema7A2/2 (n = 14) mice with
MOG35–55. Pooled data from three indepen-
dent experiments are shown.
(A) Sema7A2/2 mice are prone to die at the
onset of EAE.
(B) Sema7A2/2 animals surviving past the
disease onset exhibit a monophasic EAE
with a delayed period of recovery, compared
to relapsing-remitting EAE phenotype in wild-
type animals.
(C) Elevated levels of IFNg in the serum of
Sema7A2/2 mice 11 days postimmunization
(p < 0.0014, result of unpaired t test with
one-tailed p value).
(D) Increased infiltration of CD3 lympho-
cytes into CNS in moribund Sema7A2/2 ani-
mals 11 days postimmunization with MOG.
(E) Summary of EAE course in Sema7A2/2
and Sema7A+/+ mice. Sema7A2/2 mice are
prone to increased mortality (61%) at the on-
set of disease compared to Sema7A+/+ (0%)
littermates. The onset of disease in
Sema7A2/2 mice is accelerated (mean 12.1
days compared with 14.9 days in Sema7A+/+).animal (Powrie et al., 1994). Rag22/2 host mice trans-
ferred with Sema7A2/2 or wt CD4 RBhigh CD25negative
T cells developed comparable weight loss and clinical
signs of colitis (Figure S4A and data not shown). Cotrans-
fer of Sema7A2/2 or Sema7A+/+ CD25high CD4 T regula-
tory cells equally suppressed the colitis-associated
weight loss and clinical signs of the disease (Figure S4B
and data not shown). This result suggests that
Sema7A2/2 regulatory T cells are functional and further
points to a specific defect in the naive CD4 T cells and
to their abnormal activation as a cause of the aggravated
EAE in Sema7A2/2 animals.
Exacerbated EAE Pathology in Sema7A-Deficient
Mice
Sema7A is a neuronal factor highly expressed in the
brain, where it could potentially contribute to neuronal
protection during an autoimmune disease. In order to
evaluate if Sema7A deficiency makes neurons more vul-
nerable to damage during EAE, we examined histopath-
ological changes in the CNS of wt and KO animals with
similar clinical scores. Despite the similarity in clinical
scores between the two groups of surviving animals
(Figure 2B), there were differences at the level of histo-
pathology of the lower lumbar region of the spinal
cord. In Sema7A+/+ mice in the early phase (12 days
postimmunization, prior to EAE onset), very little inflam-
mation was detectable (Figure 3A, left panel). In contrast,
in Sema7A2/2 mice, there was a noticeable influx ofmononuclear cells to the spinal cord at the same time
points (Figure 3A, right panel). At day 26 postimmuniza-
tion, wt and KO animals of equal clinical scores (EAE =
0.5) were compared. Inflammation and demyelination
were more pronounced in the lower spinal cord of
Sema7A2/2 mice compared to wt animals, with Waller-
ian degeneration, and remyelination (Figure 3B, lower
right panel). However, while inflammation and demyelin-
ation were more widespread and appeared earlier in
Sema7A2/2 mice (Figure 3C), no additional neuronal
changes unrelated to inflammation were observed.
Therefore, Sema7A deficiency in the EAE model appears
to affect only cells of the immune system and does not
seem to play any detectable role in neuronal protection.
Enhanced Delayed Type Hypersensitivity Response
in Sema7A2/2 Mice
To further determine if the lack of Sema7A is responsible
for a generalized defect in activation of CD4 T cells
in vivo, we analyzed the induction of a delayed type hy-
persensitivity (DTH) response by sensitizing Sema7A2/2
and wt animals with a chemical skin irritant, oxazolone.
Activated CD4 T cells play a major role in DTH by emi-
grating to the irritated skin areas and producing inflam-
matory cytokines, resulting in a local tissue swelling
(Kobayashi et al., 2001). The extent of ear swelling, mea-
sured 48 hr postchallenge, was significantly greater in
the Sema7A2/2 than in wt animals upon secondary
challenge (Figure S5). This exaggerated DTH response
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in EAE.
T Cell-Autonomous Role of Sema7A in Limiting
Autoimmunity
While the pathology of EAE is mediated in large part by
T cells, the contribution of other cells types is essential
(Kuchroo et al., 2002) and could potentially play a role
in the high mortality of Sema7A2/2 mice at the onset of
EAE. To determine the contribution of Sema7A defi-
ciency specifically in T cells, we purified naive CD4
T cells from Sema7A2/2 or wt littermates, labeled them
with CFSE, and transferred one million cells per mouse
into Sema7A+/+, T cell-deficient recipients (Rag22/2 or
TCRa2/2). Twenty-four hours later, mice were immu-
nized with MOG35–55. Within 6–9 days, all the mice
receiving Sema7A2/2 T cell, but none of the Sema7A+/+
T cell recipients, became moribund or died (Figure 4A).
Figure 3. Histopathology of EAE in Sema7A+/+ and Sema7A2/2Mice
(A and B) Toluidine-blue-stained epoxy sections (1 mm) from the
lower lumbar spinal cord region. (A) At 12 days postinduction of
EAE, Sema7A2/2 mice show inflammation and increased number
of lymphocytes in L5 region of spinal cord, which is not seen in wt
littermates. (B) 26 days postimmunization, sections from Sema7A2/2
mice (B, right) (S1 spinal cord) showed infiltration of lymphocytes,
and demyelination (lower right). Demyelination was less pronounced
in Sema7A+/+ mice (B, left) (S1 spinal cord), but an influx of inflamma-
tory cells was observed.
(C) Distribution and severity of histopathological signs. Sections of
representative mice were evaluated blindly with scores between
0.5–4 for inflammatory cell infiltrates and demyelinated axons. Means
are based on three slides with two animals per group.Sema7A2/2 T cell recipients had higher serum con-
centrations of IFNg, IL-6, and KC-1, compared to
Sema7A+/+ T cell-recipient mice (Figure S3D and data
not shown). The immunofluorescent staining revealed
higher numbers of Sema7A2/2CD4 T cells in the cerebel-
lar sections from transfer recipients, which were not seen
in wt T cell recipients (Figure 4B, left panels). The bright
CD11b staining, indicative of activated microglia, is a
likely effect of IFNg production by infiltrating Sema7A2/2
CD4 T cells and was not observed in wt T cell recipients
(Figure 4B, right panels). The activated Sema7A2/2T cells
displayed a robust expansion, making up to 50% of total
cells in the spleen, compared to a more modest prolifer-
ation (2%–3% of total spleen cells) in wt T cell recipients
(Figures 4C and 4D). Sema7A2/2 CD4 T cells showed
increased expression of activation markers, such as
CD25, compared to Sema7A+/+ T cells (Figure 4E). Thus,
the hyperactivity of Sema7A2/2 T cells is likely due to the
lack of a T cell-autonomous inhibitory effect of Sema7A,
as all other cells in the recipient mice were Sema7A
sufficient.
Increased Homeostatic Proliferation
of Sema7A-Deficient T Cells
We next examined the role of Sema7A in T cells in homeo-
static proliferation. Homeostatic proliferation in lympho-
penic hosts is controlled primarily by cytokines and
low-affinity interactions of T cells with self-antigens and
has been linked with T cell-mediated autoimmunity
(Gallegos and Bevan, 2004; Surh and Sprent, 2000). We
transferred one million of naive Sema7A2/2 or littermate
wt CD4 T cells into Rag22/2;Sema7A+/+ lymphopenic
hosts to compare their homeostatic proliferation. Within
6 days posttransfer, the Sema7A2/2 T cells showed
greater expansion compared to wt T cells (Figures 5A
and 5B). Time-course analysis revealed that Sema7A2/2
CD4 T cells showed a greater degree and faster kinetics
of proliferation compared to Sema7A+/+ T cells (Fig-
ure 5C). These data demonstrate that Sema7A ex-
pressed in T cells negatively regulates lymphopenia-
induced T cell proliferation.
Sema7A Negatively Regulates TCRDownmodulation
and Signaling
TCR-mediated T cell activation is controlled by a number
of parameters, including the duration of the TCR signal-
ing. Upon TCR stimulation, cell surface expression of
TCR declines rapidly as components of the TCR signal-
ing complex are targeted for degradation through the
endocytic pathway (Duan et al., 2004; Geisler, 2004).
Sustained surface expression of TCR can interfere with
termination of downstream signals and result in pro-
longed triggering of the T cells, causing their hyperacti-
vation (Naramura et al., 2002). To determine the effect of
Sema7A on TCR signaling, we activated T cells with
plate-bound anti-CD3 antibody and analyzed changes
in the TCR surface expression by flow cytometry. We
found that anti-CD3 stimulation led to a downregulation
of surface TCR expression in Sema7A+/+ CD4 T cells,
whereas this TCR downregulation was markedly de-
layed in Sema7A2/2 T cells (Figure 6A). After 8 hr of
anti-CD3 stimulation, the wt cells lost about 90% of their
TCR surface expression. In contrast, the Sema7A2/2
CD4 T cells had retained more than 40% of the TCR level
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595Figure 4. Increased Expansion of Sema7A2/2
CD4 T Cells in a Lymphopenic Host
Rag22/2 mice received 1 3 106 FACS-sorted
CFSE labeled CD4 cells from Sema7A2/2 or
Sema7A+/+ littermates intravenously. 1 day
posttransfer, mice were immunized with
MOG35–55.
(A) Rag22/2mice (n = 8) receiving Sema7A2/2
T cells became moribund and died rapidly
within 6–9 days following immunization, while
mice receiving Sema7A+/+ T cells (n = 8) re-
mained healthy.
(B) ImmunofluorescentdetectionofSema7A2/2
or Sema7A+/+ CD4 (red, left) and detection
of CD11b (red, right) in brain sections of
TCRa2/2 mice. Results are representative of
three experiments.
(C–E) Typical profiles of splenocytes from
Rag22/2 recipients 6 days postimmunization.
(C) Dilution of CFSE label in transferred CD4
T cells. (D) Expansion of CD T cells is greatly
enhanced in Sema7A2/2 cell recipients (n = 4/
group 6 SD). (E) Activated CD4 T cells with
high CD25 surface staining are more numer-
ous in spleens of Sema7A2/2 CD4 than
Sema7A+/+ CD4 recipients.of unstimulated cells (Figure 6B). Similar results were
observed in CD8 T cells (data not shown).
As sustained surface expression of TCR is known to
correlate with increased calcium signaling, we com-
pared calcium mobilization upon anti-CD3 crosslinking
in Sema7A+/+ and Sema7A2/2 CD4 T cells. We found
that the magnitude of Ca2+ mobilization in Sema7A-de-
ficient T cells was higher and decayed at a slower rate
than in the control wt cells (Figure 6C).
TCR activation leads to rapid phosphorylation of ZAP-
70 and activation of the ERK-MAP kinase pathway (Qian
and Weiss, 1997). The comparison of tyrosine phos-
Figure 5. Homeostatic Proliferation of CD4 T Cells
(A) Increased homeostatic proliferation among Sema7A2/2 CD4
cells compared to Sema7A+/+ cells in lymphopenic host.
(B) Mean of CD4 T cells determined by surface antibody staining and
FACS analysis (n = 4/group 6 SD).
(C) Time course of homeostatic proliferation of transferred naive
CD4 T cells labeled with CFSE and followed 2, 4, and 6 days after
transfer. Shown are CFSE-dilution profiles of gated CD4 CD3 cells.phorylation patterns between wt and Sema7A2/2 T cells
revealed no global differences in major phosphorylated
bands, which include Zap70 and components of the
TCR complex (data not shown). One of the downstream
targets of TCR activation is glycogen synthase kinase 3
(GSK-3), which negatively regulates antigen-specific T
cell proliferation by acting on nuclear factor of activated
T cells (NF-AT) (Ohteki et al., 2000). In response to TCR
signal, GSK-3 is inactivated by phosphorylation, which
releases the inhibitory effect on T cell activation, while
increased inhibition of GSK-3 leads to hyperproliferation
of T cells (Ohteki et al., 2000). We observed a modestly
increased inhibitory phosphorylation of GSK-3a/b on
Ser21/9 in response to TCR stimulation in Sema7A2/2
T cells, compared to wt T cells (Figures 6D and 6E).
The S6 ribosomal kinase (S6K) is required for cell growth
and G1 cell-cycle progression and is a target of TCR-in-
duced PDK1 kinase activity (Lee et al., 2005; Pullen et al.,
1998). We found that in Sema7A2/2, T cells the phos-
phorylation of S6K is modestly increased in strength
(Figure 6E) and duration (Figure 6D), in comparison to
the wt T cells. TCR-induced ERK activation was similar
in Sema7A2/2 and wt T cells (Figures 6D and 6E).
Activation of T cells through the T cell receptor (TCR)
triggers b1-integrin signaling and induces phosphoryla-
tion of focal adhesion kinase (FAK) (Iwata et al., 2000).
Considering the evidence of Sema7A in b1-integrin func-
tion in neurons (Pasterkamp et al., 2003), we analyzed the
FAK activation in Sema7A-deficient cells. We activated T
cells with a combination of anti-CD3/CD28 antibodies.
Within 10 min, the wt T cells exhibited a robust phosphor-
ylation of FAK at Y925, which was diminished in the
Sema7A2/2 T cells (Figure 6F). We observed similar FAK
phosphorylation defect in Sema7A2/2macrophages ac-
tivated with collagen IV or with IGF-I (Figure S6A). TCR-
mediated phosphorylation ofFAK at Y925 creates a bind-
ing site for the adaptor proteins Gads/Grb2 which could
negatively regulate T cell signaling by bringing inhibitory
regulatory molecules into the proximity of the TCR com-
plex (Schlaepfer and Hunter, 1996).
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KO CD4 T Cells
(A) Anti-CD3 stimulation induced TCR surface
downregulation. T cells were stimulated with
plate bound CD3 for indicated time, and sur-
face TCR retention was determined by flow
cytometry. Shown is TCRb surface staining
of gated CD4-positive population (filled histo-
grams, wt; open histograms, Sema7A2/2).
(B) Quantification of anti-CD3 induced TCR
downregulation.
(C) Enhanced calcium mobilization in
Sema7A2/2 CD4 T cells. Histograms repre-
sent calcium flux measured by flow cytome-
try. Control: addition of secondary antibody
alone.
(D and E) Lysates of naive CD4+ Sema7A+/+ or
Sema7A2/2 T cells (D) coated with anti-CD3
antibody on ice and incubated with crosslink-
ing antibody for indicated times, or CD4+
Sema7A+/+ or Sema7A2/2 effector T cells (E)
activated for 10 min with anti-CD3/anti-CD28
antibodies were analyzed for kinases phos-
phorylation by Western blotting.
(F) Western blot of OTII CD4+ Sema7A+/+ or
Sema7A2/2 effector T cells activated for 10
min with anti-CD3/CD28 antibodies shows
diminished FAK phosphorylation. Results
representative of three independent experi-
ments.Thus, with the exception of TCR downmodulation,
Ca2+ mobilization, and FAK phosphorylation, Sema7A2/2
T cell did not exhibit any dramatic enhancements in
signaling events when stimulated with plate bound
anti-CD3/CD28 antibodies in the absence of APCs. Fur-
thermore, stimulation with anti-CD3, in contrast to the
APC-induced hyperproliferation of Sema7A2/2 T cells
(Figure 1), led to a diminished Sema7A2/2T cells prolifer-
ation compared to wt T cells (Figure S6B). Activation of
T cells with APC-independent stimuli such as anti-CD3
antibody crosslinking delivers a strong and nonspecific
signal to the T cell and bypasses a number of signals
that are otherwise delivered by an APC. Therefore, it is
likely that while anti-CD3 activation allows visualization
T cell signaling in the absence of contaminating APCs,
the actual differences in signaling between wt and
Sema7A2/2 T cells could only be revealed when T cells
are activated by professional APCs.
Sema7A2/2 Functions in T Cell Activation by APCs
The hyperproliferation of Sema7A2/2 T cells stimulated
with DCs, but not with anti-CD3/CD28 antibodies in
the absence of APCs, suggested that interaction of
Sema7A with a receptor present on APC might be nec-
essary to execute the inhibitory function of Sema7A in
the T cell. To test this hypothesis, we activated
Sema7A+/+ and Sema7A2/2 T cells with DCs pulsed
with superantigen, SEA (staphylococcal enterotoxin A).
This antigen-nonspecific activation resulted in hyper-proliferation of Sema7A2/2 T cells compared to wt cells
(Figure 7A), similarly to the antigen-specific stimuli
(Figure 1). This result implies an interaction of Sema7A
with a receptor on DCs. Fixed DCs pulsed with SEA sim-
ilarly resulted in an increased proliferation of Sema7A2/2
T cells, indicating that Sema7A2/2 T cells are not simply
more responsive to other activating signals, such as
cytokines, produced by DCs.
Sema7A may affect the TCR complex through a pro-
tein-protein interaction on the cell surface, and that in-
teraction may be stabilized by the presence of a Sema7A
receptor on the APC. Consistent with this prediction, we
noticed that while staining of the TCRb on the cell sur-
face is identical in Sema7A2/2 and Sema7A+/+ cells
(Figure 6A, top panel), staining of CD3 is decreased on
Sema7A2/2 CD4 T cells (Figure 7B). As the levels of
TCR and CD3 are equal on the plasma membrane (Call
and Wucherpfennig, 2005), this result suggests that
CD3 in Sema7A2/2 T cells is not fully accessible to the
antibody, either because of a conformational change
or obstruction of the surface part of CD3 by another
molecule. Thus, Sema7A appears to directly affect the
components of the TCR complex.
These results lead us to propose a tentative mecha-
nism of Sema7A function in CD4 T cells. As shown in
Figure 7C, left panel, Sema7A normally present on the
surface of a T cell interacts with the components of
the TCR/CD3 complex during T cell activation by an
APC. A putative receptor present on APC (presumably
Negative Control of T Cells by Semaphorin 7A
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atively regulates the TCR. In the absence of Sema7A,
this negative regulatory mechanism is lost, resulting
in enhanced activation and hyperproliferation of CD4
T cells (Figure 7C, right panel).
Discussion
In this report, we describe a crucial function of a neuronal
guidance factor, Semaphorin 7A, in the negative regula-
tion of T lymphocyte function. We find that Sema7A-
deficient T cells are hyperactive in response to activa-
tion in vivo and in vitro. This phenotype is particularly
accentuated in wild-type lymphopenic hosts receiving
small numbers of Sema7A-deficient T cells followed by
immunization with self-antigen, which leads to a mas-
sive, unrestrained T cell expansion and a subsequent
death of the host animal. This hyperactive phenotype
correlates well with our finding that Sema7A knockout
mice undergo a markedly different and more severe
course of EAE compared to their Sema7A-sufficient lit-
termates. The Sema7A-deficient animals are prone to
die near the onset of clinical EAE, and that correlates
with the increased infiltration of CNS by lymphocytes,
which we observed in the moribund Sema7A knockout
Figure 7. Sema7A Regulates T Cell Activation by APCs
(A) Sema7A2/2 T cells activated with live of fixed DCs pulsed with
staphylococcal enterotoxin A (SEA) show increased proliferation
compared to wt T cells. T cell proliferative responses are expressed
as the mean 6 SE of triplicate cultures.
(B) Surface staining of CD33 is decreased in Sema7A2/2 CD4 T cells
compared to Sema7A+/+ cells.
(C) Model of Sema7A function in T cell signaling. Sema7A interacts
with the components of TCR complex and with a putative receptor
on APCs. This interaction stabilizes TCR/CD3 complex and pro-
motes inhibitory signals that limit T cell proliferation. In the absence
of Sema7A, the TCR/CD3 complex is destabilized, and upon activa-
tion by an APC, negative regulatory signals are impaired, leading to
overt activation and T cell hyperproliferation.animals. We did not find any obvious neuron-specific
role for Sema7A in neuronal survival and protection in
the EAE model. We also provide evidence of an en-
hanced T cell-mediated delayed-type-hypersensitivity
reaction in Sema7A-deficient mice, and this observation
is in agreement with the general hyperactive phenotype
of Sema7A2/2 T cells. The hyperactivity of Sema7A2/2 T
cells is not dependent on antigen stimulation because
the enhanced T cell proliferation is evident even in
homeostatically proliferating T cells from Sema7A2/2
mice. Collectively, these results demonstrate that
Sema7A negatively regulates T cell activation and func-
tions in a T cell-specific manner. Sema7A deficiency
results in an enhanced T cell proliferation triggered by
either antigen or lymphopenia. However, Sema7A-defi-
cient mice do not develop any obvious autoimmune
disorders, and T cell hyperactivity is most strongly pro-
nounced under conditions of experimentally induced
autoimmunity or lymphopenia, pointing to a specific,
rather than general, inhibitory role of Sema7A.
Based on the T cell transfer experiments, we conclude
that the mechanism of Sema7A activity is largely T cell
intrinsic. Engagement of T cell receptors by an antigen
leads to activation, cell proliferation, differentiation,
and effector functions. It has been proposed that the ini-
tiation and propagation of the signaling events taking
place in immune cells occur in specialized membrane
regions, lipid rafts, where the lymphocyte receptors lo-
calize (Magee et al., 2002). The GPI (glycosylphosphati-
dylinositol)-linked proteins localize to lipid rafts, and
many of them were shown to play important roles in
T cell activation (Hwa, 2001; Loertscher and Lavery,
2002; Magee et al., 2002). We propose that similarly
to several other T cell-specific GPI-linked proteins,
Sema7A may interact in cis and negatively regulate the
TCR complex within lipid rafts. Furthermore, our data
indicates that Sema7A may somehow control the func-
tional conformation of the TCR complex.
While many different biochemical pathways regulate
T cell activation, TCR downmodulation and internaliza-
tion are important means of negative regulation. Previous
work utilizing E3-ligase Cbl knockout animals showed
a critical role of TCR downregulation in T cell responsive-
ness, as in the T cells from these mice theabnormal reten-
tionof T cell receptor on the cell surface causes sustained
TCR signaling (Naramura et al., 2002). In addition, Cbl-
b knockout T cells show a hyperproliferative phenotype
and develop autoimmunity, indicating that alterations in
TCR downmodulation and negative regulation can lead
to detrimental effects in the host (Bachmaier et al.,
2000; Chiang et al., 2000; Krawczyk et al., 2000). We
find that TCR downregulation upon stimulation is defec-
tive in Sema7A2/2 T cells. The surface retention of TCR
correlates with an enhanced and sustained calcium
mobilization.
TCR-mediated cell signaling events are tightly regu-
lated, as even small alterations in the TCR sensitivity
can lead to changes in T cell activation and proliferation
(Qian and Weiss, 1997). We found that CD4 T cells lack-
ing Sema7A show slightly enhanced activation of S6K
and calcium influx, as well as increased inhibitory phos-
phorylation of GSK-3. Increased inhibition of GSK-3 has
been linked with T cell hyperproliferation (Ohteki et al.,
2000). We also demonstrate a defect in activation of
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ative regulators to the proximity of TCR (Schlaepfer
and Hunter, 1996), although the functional significance
of defective FAK activation is currently unclear. Interest-
ingly, hyperresponsiveness of Sema7A-deficient T cells
could only be observed upon T cell stimulation by pro-
fessional APCs, suggesting a contribution of DC-derived
signal to Sema7A-mediated negative regulation of T cell
activation.
With the use of superantigen SEA, we find that an
antigen-independent but APC-dependent activation of
Sema7A-deficient T cells leads to their hyperprolifera-
tion and that increased response is preserved if fixed
DCs are used as APCs. This suggests that part of the
normal activation of T cells by APCs is the inhibitory sig-
naling that limits T cell proliferation. It is likely that
Sema7A interacts with a putative receptor expressed
on DCs and that this interaction may be required to pro-
mote inhibitory function of Sema7A in TCR signaling.
Our data provide evidence for Sema7A function in TCR
signaling that could involve either a direct association of
Sema7A/TCR or possibly another molecule serving as
the linker. The diminished antibody accessibility of
surface CD3 in Sema7A2/2 T cells indicates that the ab-
sence of Sema7A has a direct effect on the TCR complex
composition or conformation, and that may contribute to
the defects of T cell signaling seen in Sema7A-deficient
T cells. The nature of the Sema7A counter structure re-
mains puzzling. Recent report of the Plexin C1-deficient
animals demonstrated only a small defect in T cell func-
tion in these mice and completely normal function of
APCs (Walzer et al., 2005). While it remains possible
that Plexin C1 plays some role in Sema7A signaling in
T cells, it is likely that another receptor, possibly an integ-
rin, plays a more relevant role. Our observations indicate
that such receptor may function in trans with Sema7A
and may be expressed on the DCs.
Based on the available evidence, we propose a model
that predicts that Sema7A exists in a complex with the
TCR and/or CD3 on the T cell surface. During T cell acti-
vation, Sema7A engages a receptor on the APC. This en-
gagement may serve to change the conformation of
Sema7A to make it active, or alternatively it may serve
to position Sema7A within the T cell: APC synapse. Ac-
tivity of Sema7A manifests in limiting T cell proliferation
by promoting induction of the inhibitory signaling mech-
anisms. In the absence of Sema7A, TCR/CD3 signaling
and complex assembly is impaired. This impairment
may in part stem from the altered CD3 activity, defective
TCR internalization, and altered intracellular signaling. In
the absence of Sema7A, this negative regulatory mech-
anism is lost, resulting in an abnormally strong activa-
tion and hyperproliferation of the T cells. Conversely,
providing additional soluble Sema7A inhibits T cell sig-
naling and decreases proliferation.
Previous studies have demonstrated immunological
function of several members of Semaphorin family, in-
cluding Sema4A, Sema4D, and PlexinA1 (Bismuth and
Boumsell, 2002; Kumanogoh and Kikutani, 2003; Wong
et al., 2003). In each of these cases, the mechanism of
Semaphorin or Semaphorin receptor function in the
immune system is different. The present study, together
with previous reports (Holmes et al., 2002; Mine et al.,
2000), demonstrates that Sema7A also has an importantfunction in the immune system, in addition to its function
in the nervous system, and thus adds to a growing num-
ber of signaling pathways shared by the two systems
(Trautmann and Vivier, 2001).
Experimental Procedures
Mice
Generation of Sema7A2/2 mice was described previously (Paster-
kamp et al., 2003). Male and female mice 4–6 weeks old were used
for analyses. C57BL/6 TCRa2/2 and C57BL/6 RAG22/2 mice were
purchased from the Jackson laboratory (Bar Harbor, ME) and
Taconic Farms (Germantown, NY). Animals were housed in a patho-
gen-free facility at Yale University. All procedures involving mice
were approved by Yale University Institutional and Animal Care
and Use Committee.
Reagents and Antibodies
LPS, OVA, oxazolone, and staphlococcal enterotoxin A were from
Sigma (St. Louis, MO). MOG35–55 and OTII OVA peptide were synthe-
sized and purified by Keck Facility (Yale University, CT). APC anti-
CD4, phycoerythrin (PE) anti-CD25, and rat anti-CD4 (L3T4) were all
from BD Biosciences (San Diego, CA). Anti-rat IgG-PE was from
Jackson ImmunoResearch Labs (West Grove, PA). Goat anti-rat
Alexa Fluor 594 was from Molecular Probes (Eugene, OR). Anti-
CD4, anti-CD11c, and anti-CD19 microbeads were from Miltenyi Bio-
tec (Auburn, CA). Mouse cells were cultured in complete RPMI-1640
supplemented with 10% FCS, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, 2 mM L-glutamine, 10 mM HEPES, and 1 mM sodium pyruvate
(all from Sigma). Recombinant Sema7A-FC was prepared as follows:
Sema7A with a deletion of C-terminal 25 amino acids was cloned into
a pcDNA3 vector upstreem and in frame with a human Fc fragment,
expressed in 293T cells, and purified from supernatant with protein
A column (Amersham) according to manufacturer’s instructions.
The Fc fragment was expressed in pSecTag vector and purified
by the same method. Recombinant proteins were dialyzed exten-
sively against PBS and purity was assayed by UV absorption mea-
surements.
EAE Induction and Scoring
For EAE induction, MOG35-55 (3 mg/ml in PBS) was mixed with equal
volume of complete Freund’s adjuvant (CFA, from Sigma), and 50 ml
was injected subcutaneously in each flank of Sema7A2/2 or
Sema7A+/+ littermates. Pertussis toxin (Ptx, 0.2 mg) (Biological Lab-
oratories, Inc., Campbell, CA) was given intravenously (i.v.) at the
time of immunization and again 2 days later. Mice were scored daily
for clinical signs of disease, and a numerical score was assigned
based on the severity of the disease symptoms: 0, no disease; 1,
limp tail; 2, weak tail and partial hind limb paralysis; 3, total hind
limb paralysis; 4, both hind limb and fore limb paralysis; 5, death.
Mice with a score of 4 were euthanized. Remission was defined by
a decrease in the score of at least one point for two consecutive
days. EAE was considered remitting when at least one remission
occurred within the first 26 days.
Adoptive Transfer
Pooled spleen and lymph node cells from Sema7A2/2 or wild-type
littermates were depleted with TIB 146, TIB 164, Y3JP, and TIB
128 hybridoma supernatants and rabbit complement (Cedarlane
Lab). After depletion, cells were washed in PBS/1% fetal calf serum
twice, stained with anti-CD4-APC, and sorted on FACSVantage. 13
106 CD4 cells were labeled with 5 mM Carboxy-fluorescein diacetate,
succinimidyl ester (CFSE) for 7 min, washed in sterile PBS three
times, resuspended in a final volume of 200 ml PBS, and adminis-
tered intravenously to naive C57BL/6 TCRa2/2 or C57BL/6 RAG22/2
recipient mice, and EAE was induced 24 hr after transfer. For homeo-
static proliferation studies, identical protocol was used, except the
immunization step was omitted.
Staining and Flow Cytometry
Cells were stained with relevant antibodies for 30 min on ice,
washed, and analyzed with a FACSCalibur (BD Biosciences). Data
were analyzed with FlowJo software.
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For antigen-specific T cell responses, mice were immunized in hind
foot pads with 100 mg/mouse of OVA (Sigma) and 50 mg/mouse of
LPS emulsified in Incomplete Freund’s adjuvant (IFA, from Sigma).
Draining lymph nodes were collected 6 days postimmunization.
Cell Purification
Spleen and lymph nodes were harvested from 6–12 week old mice.
Cell suspensions were incubated with anti-CD4 microbeads followed
by purification with the AutoMACS sorter (Miltenyi Biotec). In all
experiments, more than 95% of purified cells were positive for CD4.
T Cell Proliferation Assay
Purified CD4 T cells (1 3 105) from draining lymph nodes were
cultured in flat bottom 96-well plates with spleen cells (3 3 105,
1500 rads irradiated) or bone marrow DCs (2 3 104) live or fixed,
as indicated, and titrating doses of antigen for 72–84 hr. Proliferation
of T cells was determined by incorporation of [3H]thymidine for the
last 12–16 hr of culture.
ELISA
Serum samples were collected by eye bleeding from animals. Paired
antibodies for cytokine specific enzyme linked immunosorbent
assays were from Pharmingen.
Immunohistochemistry and Immunofluorescence
Wild-type and Sema7A2/2 animals were anesthetized, perfused with
ice-cold PBS, and fixed with 4% paraformaldehyde in PBS. Brains
and spinal cords were removed and frozen or paraffin-embedded
4–5 mm sections were prepared. Tissues were stained with anti-
CD3 antibody, followed by histochemical development with DAB.
For immunofluorescence, tissues were stained with anti-CD4 or anti-
CD11b (BD Biosciences) and secondary anti-rat Alexa Fluor 594.
Results representative of at least three independent experiments.
Histopathology
Slices (1 mm) of glutaraldehyde-perfused spinal cord (L5, L6, and
S1) were postfixed in 1% osmium tetroxide/Millonig’s buffer on ice
for 90 min, dehydrated in ethyl alcohol (70%, 90%, 95%, and
100%), cleared in propylene oxide, and embedded in Epon. 1 mm ep-
oxy sections were stained with toluidine blue for light microscopy.
Sections were scored by an investigator blinded to the code, on
a scale of 0 to 4 for cell infiltration, de- and remyelination, and Wal-
lerian degeneration. Representative lesions were examined from
matching levels of spinal cord in animals from both groups
(Sema7A+/+ and Sema7A2/2) with comparable disease courses
and clinical scores.
Calcium Mobilization
Purified CD4 T cells were resuspended in RPMI/10% FCS and
loaded with 3 mM Indo-1 (AnaSpec, San Jose, CA) for 30 min at
37ºC. Cells were then washed with ice-cold PBS and surface stained
with anti-CD3 for 30 min at 4ºC, followed by ice-cold PBS wash.
Immediately prior to cross linking with secondary antibody, each
sample was warmed up to 37ºC for 10 min, and calcium flux was
measured with a LSRII flow cytometer. Data were analyzed with
FlowJo software.
TCR Downregulation Measurement and Analysis
Single-cell suspensions of splenic cells were incubated for indicated
times with 2 mg/ml plate bound anti-CD33 at 37ºC. Collected cells
were surface stained with FITC anti-TCRb (H57-597), PE anti-CD4
or anti-CD8, fixed, and analyzed on FACS Calibur flow cytometer.
The percentage of TCR downregulation for each gated CD4 or
CD8 population was determined based on MFI of TCRb staining
on stimulated versus unstimulated cells. To calculate the percent
of TCR downregulation from the cell surface, the following formula
was used: (U, unstimulated; S, stimulated)
%TCR downregulation = ð½MFI Utime 02MFI Stime t=MFI Utime 03 100
Western Blotting
Naive purified CD4 T cells were incubated on ice with anti-CD3
(10 mg/ml) for 30 min, washed with ice-cold PBS, and treated withsecondary antibody for indicated times at 37ºC. Purified CD4 OTII
transgenic T cells (wt or Sema7A2/2) were cultured with irradiated
wild-type spleen cells and OVA peptide (1 mg/ml) for 4 days. Cells
were then purified, washed three times in PBS, and resuspended
in RPMI medium without serum for 6 hr and activated with anti-
CD3/anti-CD28 (at 10 mg/ml) for 10 min at 37ºC. 23 106 cells/sample
were lysed immediately following activation; total protein (100 mg)
was resolved on 10% SDS-PAGE gels. Blotting was performed
with phospho-S6 kinase T389, phospho-ERK T202/Y204, or phos-
pho-GSK3a/b S21/9 (all from Cell Signaling Technology), or mono-
clonal anti-b-actin (Sigma). Bands were visualized with the ECL
System (all from Amersham).
Statistical Analysis
Analysis of statistical significance for indicated data sets was
performed with Prism4 Graphpad software.
Supplemental Data
The Supplemental Data include six figures and are available at
http://www.immunity.com/cgi/content/full/24/5/591/DC1/.
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